Just recently, shares of Amkor Technology (AMKR) collapsed from about $28 to $22.30 on a secondary offering. Now oversold. Earnings haven’t been too shabby either. While revenues slipped 3.3% year over year, its Q2 EPS of 26 cents did beat by five cents. The company...
We’ve mentioned Microsoft (MSFT) a few times lately. And that’s because analysts continue to praise the stock. According to analysts at Citi – who have a $420 price target—artificial intelligence-related events could send the stock higher. “These include...
by Ian Cooper One of the best ways to generate reliable income is by investing in the Dividend Aristocrats. Not only have these stocks paid out dividends for more than 25 years, they’re also some of the most reliable companies on the planet – even in the worst of...
Global leaders want to put millions of electric vehicles (EVs) on the roads. President Biden, for example, wants 51% of all new autos to be electric by 2030. Even the International Energy Agency (IEA) believes we could see EV sales reach 14 million this year from 10...
After consolidating around $116 for the last few months, Oracle (ORCL) is breaking out. Now, if it can break above resistance around $127.50, it could potentially rally well above $130. Helping, Barclays analysts upgraded the ORCL stock to overweight, with a...
Keep an eye on oversold shares of Electronic Arts (EA). While the stock gapped lower on disappointing bookings, it’s a temporary setback, in our opinion. For one, the company is set to release even more anticipated games this year, and next, which should push bookings...
Cannabis stocks, like Tilray Brands (TLRY), could see higher highs. All after the Department of Health and Human Services said it is recommending that the Drug Enforcement Administration reclassify marijuana at a less severe schedule. In fact, Assistant Secretary for...
by Ian Cooper At the moment, pharmaceutical companies are applying artificial intelligence (AI) and machine learning (ML) to drug development. With those tools, they’re creating new drugs for a range of ailments, and potential multi-billion-dollar opportunities, says...
“Keep an eye on Netflix (NFLX). After finding double-bottom support at $400, the NFLX stock popped to $427.55. Now, if it can break above resistance at $440, it could potentially test $480 again. All thanks to its potential revenue surge from password crackdowns,” we...
As hoped, Take-Two Interactive (TTWO) is gaining momentum. The last time we mentioned the opportunity, we noted, “We still like it. Especially as it starts to pivot higher solid support, and from over-extensions on RSI, MACD, and Williams’ %R. From a...